Crucial roles of Sp1 and epigenetic modifications in the regulation of the CLDN4 promoter in ovarian cancer cells.
about
Overexpression of Cancer-Associated Genes via Epigenetic Derepression Mechanisms in Gynecologic CancerCpG methylation plays a vital role in determining tissue- and cell-specific expression of the human cell-death-inducing DFF45-like effector A gene through the regulation of Sp1/Sp3 bindingSmad7 induces hepatic metastasis in colorectal cancerClaudins overexpression in ovarian cancer: potential targets for Clostridium Perfringens Enterotoxin (CPE) based diagnosis and therapyTranscriptional regulators of claudins in epithelial tight junctionsGenome-wide modulation of gene transcription in ovarian carcinoma cells by a new mithramycin analogueSilencing of claudin-11 is associated with increased invasiveness of gastric cancer cells.Important roles of multiple Sp1 binding sites and epigenetic modifications in the regulation of the methionine sulfoxide reductase B1 (MsrB1) promoterDNA demethylation-dependent enhancement of toll-like receptor-2 gene expression in cystic fibrosis epithelial cells involves SP1-activated transcription.DNA methylation profiles in ovarian cancer: implication in diagnosis and therapy (Review)Derepression of CLDN3 and CLDN4 during ovarian tumorigenesis is associated with loss of repressive histone modificationsCpG methylation regulates allelic expression of GDF5 by modulating binding of SP1 and SP3 repressor proteins to the osteoarthritis susceptibility SNP rs143383.Transcriptional regulation of cell adhesion at the blood-testis barrier and spermatogenesis in the testis.Inhibition of Sp1-dependent transcription and antitumor activity of the new aureolic acid analogues mithramycin SDK and SK in human ovarian cancer xenografts.Gastric and intestinal claudin expression at the invasive front of gastric carcinoma.Claudins and the modulation of tight junction permeability.Splice variants and promoter methylation status of the Bovine Vasa Homology (Bvh) gene may be involved in bull spermatogenesis.Epigenetic regulation of cancer-associated genes in ovarian cancer.Epigenomics and ovarian carcinoma.MicroRNA 34c gene down-regulation via DNA methylation promotes self-renewal and epithelial-mesenchymal transition in breast tumor-initiating cells.Claudin-4 overexpression in epithelial ovarian cancer is associated with hypomethylation and is a potential target for modulation of tight junction barrier function using a C-terminal fragment of Clostridium perfringens enterotoxin.Optimizing molecular-targeted therapies in ovarian cancer: the renewed surge of interest in ovarian cancer biomarkers and cell signaling pathways.The expression patterns and correlations of claudin-6, methy-CpG binding protein 2, DNA methyltransferase 1, histone deacetylase 1, acetyl-histone H3 and acetyl-histone H4 and their clinicopathological significance in breast invasive ductal carcinomRegulation of a disintegrin and metalloprotease-33 expression by transforming growth factor-β.SENP3 regulates the global protein turnover and the Sp1 level via antagonizing SUMO2/3-targeted ubiquitination and degradationIdentification of claudin-4 as a marker highly overexpressed in both primary and metastatic prostate cancer.Analysis of single nucleotide polymorphisms in the region of CLDN2-MORC4 in relation to inflammatory bowel diseaseEmerging roles of claudins in human cancerTrichostatin-A modulates claudin-1 mRNA stability through the modulation of Hu antigen R and tristetraprolin in colon cancer cells.Epstein-Barr virus-associated gastric carcinoma: a distinct carcinoma of gastric phenotype by claudin expression profilingEpigenetic up-regulation of leukemia inhibitory factor (LIF) gene during the progression to breast cancer.Claudin and ovarian cancer.Long non-coding RNA ZFAS1 interacts with miR-150-5p to regulate Sp1 expression and ovarian cancer cell malignancy.Modulation of gene expression in ovarian cancer by active and repressive histone marks.Claudins and alveolar epithelial barrier function in the lungTight junction-related human diseases.Targeting tight junctions during epithelial to mesenchymal transition in human pancreatic cancer.Activation of KLF8 transcription by focal adhesion kinase in human ovarian epithelial and cancer cells.Mining the epigenetic landscape of tissue polarity in search of new targets for cancer therapy.Claudins in cancer: bench to bedside.
P2860
Q21129296-57CE7AFD-2674-4D9B-AE6D-659462AE6EEAQ24645280-688B99F4-7ED2-4C36-A8A2-555F3F8CEDF5Q24649660-1F848BFD-F966-4C44-90D9-4D388C9DD1C2Q26851347-3D27B3E9-754C-47F5-B2A5-83F9A7BD1643Q28261649-9DEC86AB-28BE-4891-96D6-F3EB0066B15AQ28541775-459A1B2A-58D0-435E-AA5E-9F2217C27190Q30945572-A558181C-FBB4-4794-A087-2523B0FA4CCAQ33285418-45AE39C6-4E73-4859-9BF5-23E42988E1E8Q33329317-60670239-7A4E-4135-B482-E53EC2129AF5Q33799002-D58A9B3F-9F04-4A59-A16D-B1528A805523Q33884564-EC3F5102-28A8-4655-AF42-1E3486404068Q33906541-C1C2908B-0827-4413-867F-93645B923F46Q33939295-24CEFECA-B63B-4D74-A6AF-BEC5725F4835Q33976557-92463398-E08A-4122-881B-4E65BBBF4F02Q34622776-D979C83D-2F56-4D64-8703-32784A58F822Q34650517-78D69E3E-174A-41B9-8F52-DBD74D80FDC3Q34787961-A5467C4D-F678-48CE-BCAB-0B1D05C16DE6Q34874813-32C2CD8F-1EFE-4BFA-89A7-629E1E67883BQ35636575-55B024DF-BE63-4B81-8A68-F2C8FA66E06FQ35643732-B8F9173A-F7CC-4703-B752-9640E557BDA1Q35756974-42DF2EEE-18D9-4A82-960E-83F0AECED2B9Q35837949-A69E0425-9CC6-41A1-9F73-4D671B2CDE60Q35950987-139C0D76-954B-419A-B57B-97C77686BE56Q35987171-40BD816D-D763-4469-B0CE-5D6DFC98FEE7Q36447897-B679251D-CC1A-4E96-8EE3-79FE1D359795Q36858042-0227ED58-4399-4CE1-B0F6-939E79980229Q37087507-92D110B0-739B-4767-97B5-91EDE272B925Q37225107-623C8534-E87F-43A7-B944-5B841B39E725Q37262149-2C5C9352-E3AB-4770-BB5D-C877900022EBQ37267958-F6CACFE6-5450-450F-8D37-CE67A14806AAQ37599413-2E5B6273-BD29-473A-873A-653048307351Q37611453-3239FE9B-5AEB-427F-A2D9-076370130481Q37746055-C1A413C4-0AA0-4B4B-B114-A4769169F3E4Q37962015-3DC1F5B4-A7D2-41F2-9FDB-72C8DCEF13A8Q38016500-E229A385-2C10-470C-99AD-F44C0CFCB8EFQ38077200-6B447663-E664-4AC5-BAFD-88C16FA4E4B2Q38242808-3CFC7C5E-80CC-441C-98D9-76AF111F091FQ38292525-E9B89020-F58B-4255-A683-3C65A3B93DE2Q38662513-C4B001E8-59F6-427F-B28C-FB67806E10EAQ38953546-F0F43913-49C3-47BA-98C4-41CA4999DCF3
P2860
Crucial roles of Sp1 and epigenetic modifications in the regulation of the CLDN4 promoter in ovarian cancer cells.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Crucial roles of Sp1 and epige ...... moter in ovarian cancer cells.
@en
type
label
Crucial roles of Sp1 and epige ...... moter in ovarian cancer cells.
@en
prefLabel
Crucial roles of Sp1 and epige ...... moter in ovarian cancer cells.
@en
P2093
P2860
P356
P1476
Crucial roles of Sp1 and epige ...... moter in ovarian cancer cells.
@en
P2093
Hiroshi Honda
Hongxiu Ji
Patrice J Morin
Roman P Wernyj
P2860
P304
21433-21444
P356
10.1074/JBC.M603767200
P407
P577
2006-05-19T00:00:00Z